Pomalidomide Pomalid 1mg | Anticancerdrugs | MHP - PowerPoint PPT Presentation

About This Presentation
Title:

Pomalidomide Pomalid 1mg | Anticancerdrugs | MHP

Description:

Pomalidomide is sold under the brand name Pomalid 1mg and it belongs to anti neoplastics drugs, Pomalid 1mg is doable as orally bioavailable thalidomide derivative asssociated with numerous therapeutic activities @MHP – PowerPoint PPT presentation

Number of Views:10
Slides: 18
Provided by: mersarlin13
Category:
Tags:

less

Transcript and Presenter's Notes

Title: Pomalidomide Pomalid 1mg | Anticancerdrugs | MHP


1
Pomalidomide Pomalid 1mg Anticancerdrugs MHP
2
POMALID 1MG DEFINE
  • Pomalidomide is sold under the brand name Pomalid
    1mg and it belongs to anti neoplastics
    drugs Pomalid 1mg is doable as orally
    bioavailable thalidomide derivative asssociated
    with numerous therapeutic activities such as
    immune modulatory, anti-angiogenesis, anti
    neoplastic. Pomalid 1mg combination with
    dexamethasone will cause liver injury

3
POMALID 1MG CLINICAL USE
  • The primary indication of Pomalid 1mg is used in
    the treatment of Multiple Myeloma condition. In
    this condition, Pomalid 1mg tablet is used by
    combining with dexamethasone. Pomalid
    1mg capsules are applicable in Previously the
    Patients treated with two treatment such as
    proteasome inhibitor Lenalidomide. Patients who
    are suffered with disease progression
    condition Pomalid 1mg tablet treatment should be
    followed within 60 days in patients who are
    concluded the last treatment.

4
POMALID 1MG WORKS AS
  • Pomalid 1mg tablet has three primary
    pharmacological activities against cancer cells.
    Pomalidomide includes in the way cancer
    proliferation and provoke the apoptosis of cancer
    cells. Pomalidomide enhance the T cell natural
    killer cells interceding immunity inhibits the
    formation of pro inflammatory cytokines from
    monocytes. Pomalidomide forbid the new cell
    formation. The binding of Pomalidomide to active
    site of targeted cell causes inhibition of
    ubiquitin ligase action.

5
ADME PROPERTIES
  • The time to high serum concentration of
    Pomalidomide is reaches between 2 to 3 hours. It
    should be administered with or without food.
    Hence No effect of food should be produced
    Volume of distribution of Pomalidomide is between
    62 138L in steady state.
  • The Pomalidomide distribution by 67 of serum
    level at after 4 hours of drug intake. human
    plasma protein by bounding range of 12 44.
    Hepatically mediated through CYP1A2, CYP3A4 is
    Pomalidomide is metabolized.

6
ADME PROPERTIES
  • Pomalidomide clearance value is 7 to 10L/hr.
    Doses are excreted via urine 73 feces 15
    respectively. Doses are excreted as an unchanged
    form via urine 2 feces 8. Pomalidomide half
    life period is 9.5 hours.

7
Pomalid 1mg
  • Brand  Pomalid 
  • Ingredients  Pomalidomide 
  • Strength  1mg 
  • Manufactured  Natco 
  • Package  21 Tablets

8
DOSAGE MANAGEMENT
  • DURING MULTIPLE MYELOMA MALIGNANCIES
  • The dosage recommendation of Pomalid 1mg is 4mg
    should be administered as a single dose for 1 to
    21 days of successive 28 day cycles. Pomalid is
    combined with dexamethasone with low dose.
    Administrate Dexamethasone on day 1, 8, 15 22
    of each 28 day cycle. The prescribed dose of
    dexamethasone is 40mg should be administered the
    patient having weight about 75kg. The
    prescribed dose of dexamethasone is 20mg given
    for patients weight Greater than 75kg

9
DOSAGE MANAGEMENT
  • DOSAGE ALTERATION DURING HEMATOLOGICAL
    TOXICITIES NEUTROPENIA
  • ANC lt500/mcL Pomalid treatment should be
    postponed and check the CBC weekly. ANC
    500/mcL Pomalid therapy should be continued by
    3mg/day For each successive drop lt500/mcL
    Pomalid 1mg should be postponed. ANC 500/mcL
    Continue the Pomalid therapy with 1mg/day.

10
THROMBOCYTOPENIA
  • Platelets count lt25000/mcL Pomalid therapy
    should be postponed and check CBC Platelets count
    50000/mcL 3mg of Pomalid should be taken daily

11
WITH STRONG CYP1A2
  • Pomalid combined with CYP1A2 substrates causes
    increasing the plasma concentration of
    Pomalidomide and leads to elevate the risk of
    Pomalidomide.

12
IN RENAL DAMAGED PATIENTS
  • In severe renal impaired patients, the suggested
    dose of Pomalid is 3mg per day.
  • IN HEPATIC IMPAIRED PATIENTS
  • The advised dose is 3mg/day in severe
    condition, the suggested dose is 2mg/day given
    for mild to moderate patients.

13
Pomalid 1mg
  • POMALID 1MG DRUG INTERACTION
  • Pomalid 1mg concurrently used with CYP1A2 drugs
    causes increased concentration of Pomalidomide.
    Overcome this problem by reducing the dose
    of Pomalid 1mg during this combination
    therapy.POMALID 1MG CONTRAINDICATION
  • Pomalid 1mg is contraindicated to Pregnancy
    Lactation Hypersensitivity reactions produced due
    to patients are contraindicated to the component
    of Pomalid 1mg .POMALID 1MG WARNING
  • The most probable worsening condition of Pomalid
    1mg is Venous arterial thromboembolism Embryo
    fetal damage

14
Pomalid 1mg
15
PRESCRIPTION
  • Millionpharma.com , a fully licensed and
    regulated pharmacy medicine, takes all
    precautions to strictly abide by the laws and
    regulations set forth in the dispensing of
    prescription medications. By placing the order
    for your prescription medicines, you acknowledge
    and accept the following terms regarding the
    purchase of any prescription medicines.  Million
    pharma.com will not dispense any prescription
    medication without a valid prescription from a
    licensed physician.  If you are ordering
    prescription medication(s), you hereby confirm
    that you will send us a scanned copy of your
    valid prescription(s) via email, fax, Whatsapp,
    or by post, and this prescription shall then be
    subject to the scrutiny of and approval by our
    qualified Pharmacists. 

16
PRESCRIPTION
  • The drug information provided in
    the Millionpharma.com is for informative purposes
    only and this Website is not intended to provide
    diagnosis, treatment or medical advice. We are
    not liable for any adverse effects or harm to you
    as a result of your reliance on the information
    in the Website.  Millionpharma.com requires
    either the User or Customer or the Caregiver to
    confirm he/she is completely aware of the
    indications, side effects, drug interactions,
    effects of missed dose or overdose of the
    medicines he/she orders from us. It is imperative
    to seek professional advice from your physician
    before purchasing or consuming any medicine
    fromMillionpharma.com  At Millionpharma.com , a
    Caregiver can order prescription medicines on
    your behalf.

17
FOR FUTHER INFO
  • MOBILE NO 91-9940472902
  • EMAIL millionhealthpharmaceuticals_at_gmail.com
  • WEBSITE URL https//millionpharma.com/pomalid-1m
    g.php
Write a Comment
User Comments (0)
About PowerShow.com